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a  b  s  t r  a  c  t
The  human  placenta  is  a multifunctional  organ  that grows  and  adapts  to  increasing  fetal  demand  and
ﬂuctuations  in  the  intrauterine  environment.  It is  subjected  to physiological  and  pathological  changes  in
local  oxygenation,  both  of  which  induce  adaptive  changes.  In early  pregnancy  a low  PO2 is  the  normal
physiological  state  and  this  is not  hypoxic—there  is  no  perturbation  of  ATP/ADP  ratios  and,  if the placenta
is  sampled  very  rapidly,  little  HIF1  is  detected  in  human  ﬁrst-trimester  placental  villi. Nonetheless,
HIF1  can  be increased  and  activated  by  culture.  However,  the placenta  does  show  evidence  of  stress
under  pathological  conditions.  For  example,  in  cases  of pre-eclampsia  where  delivery  by caesarean  sec-
tion is  necessitated  for maternal  well-being  before  34 weeks’  gestation,  placental  endoplasmic  reticulum
stress  is evident.  Cases  delivered  ≥34  weeks  are  indistinguishable  from  normal  term  controls.  One  con-
sequence  of  placental  stress,  whether  oxidative,  related  to  the  endoplasmic  reticulum  or immunological,
is  that  factors  are  released  into  the  maternal  circulation,  which  affects  the endothelium,  leading  to  the
maternal  syndrome.  Soluble  FLT1  may  contribute  directly  to  this  and  the  most  likely  mechanism  is  direct
action  on  the  maternal  endothelium.  sFLT1  is able  to form  a heterodimer  with  cell  surface  VEGF  receptors
and is  therefore  able  to have  a dominant  negative  effect  (in  addition  to acting  as  a  competitive  inhibitor
by  simply  binding  vascular  endothelial  growth  factor  A  [VEGFA]  and  placental  growth  factor  [PlGF]).  This
leads in  vitro  to the  sensitisation  of endothelial  cells  to  low  levels  of  TNF.
©  2015  Z. Published  by  Elsevier  Ireland  Ltd. This  is an  open  access  article  under  the CC BY  license. Placental stress
In human pregnancy the outermost layer of the placental villi
s formed of the syncytiotrophoblast. This is a continuous barrier
nd mediates exchange functions between the fetal and the mater-
al circulations. It also performs an important endocrine function,
ecreting numerous proteins. Many of the proteins necessary for
hese two functions are glycosylated. Some of the most abundantly
ecreted placental proteins are in fact the pregnancy-speciﬁc gly-
oproteins and, in ruminants, pregnancy-associated glycoproteins
PAGs) (Moore and Dveksler, 2014; Wallace et al., 2015). In addi-
ion, the well-known placental glycoprotein hormone family in
umans includes placental lactogen and hCG (Fournier et al., 2015).
t is also worth noting that protein synthesis, such as is neces-
ary to produce large amounts of secreted glycoprotein hormones,
onsumes considerable amounts of cellular energy; indeed, the
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formation of a single peptide bond consumes a total of four high-
energy phosphate groups.
2. Placental hypoxia?
A considerable portion of the current literature relating to pre-
eclampsia implicates some form of “stress”, which affects the
placenta, leading to compromise of its function. This in some way
leads to the release of factors that subsequently affect maternal
and fetal physiology. Much of the focus of the placental stress is
attributed to a defect in spiral arterial remodelling that in turn may
be due to perturbation of immunological interactions with decidua
(Burton et al., 2009). The “stress” that the placenta experiences has
been variously categorised as oxidative stress, endoplasmic reti-
culum stress, and immunological stress (Roberts and Bell, 2013).
Particularly in relation to oxidative stress, many papers describe
the placenta as “hypoxic” during the ﬁrst trimester. Indeed, such
terminology is commonly used when describing normal placental
development and is based on the now well-accepted data that the
PO2 in the ﬁrst trimester of the human placenta is approximately
20 mmHg  (Jauniaux et al., 2000). However, the authors who made
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he primary observations do not describe placenta as “hypoxic”
nywhere in the manuscript. They carefully report the PO2 and
escribe placental development as normally occurring in a low oxy-
en environment. Thus, this is the normal physiological state and
here are no signiﬁcant differences in the ATP/ADP ratio nor in the
oncentrations of NAD+, lactate or glucose among ﬁrst-, second- or
hird-trimester samples (Cindrova-Davies et al., 2014). Indeed, the
ocal PO2 is different in different tissues; for example, in liver and
uscle it is ∼30 mmHg, in the kidney it is ∼50 and 10–20 mmHg  in
he cortex and medullar respectively and in the superﬁcial regions
f the skin it is ∼8 mmHg  (Carreau et al., 2011). Recent work has
hown that there is considerable variation in oxygen tension over
hort distances within the bone marrow (Spencer et al., 2014). Thus,
he PO2 of the normal ﬁrst-trimester placenta is not so different
rom many of these values.
Many of the key cellular responses to low oxygen are mediated
y hypoxia-inducible factor 1 and several authors have reported
he presence of this protein (or more accurately the  subunit)
n ﬁrst-trimester villi (Ietta et al., 2006). This has frequently been
ited as evidence that the ﬁrst trimester villi are “hypoxic”. How-
ver, HIF1, while it is clearly induced by low oxygen, can also
e induced by a variety of other stresses that include oxidative
tress. Furthermore, the induction, or more accurately the stabi-
isation of the HIF1, can also be inﬂuenced by a variety of stress
esponse kinases. Thus, inferring that a tissue is hypoxic merely
n the basis that the HIF1 is detected may  be imprudent (Pringle
t al., 2010; Kuschel et al., 2012). We  have recently shown that
rst-trimester human villi collected using a method akin to chori-
nic villi sampling in which the tissue is removed and frozen within
econds contain only modest amounts of HIF1. If such tissue is cul-
ured then the level of HIF1 immunostaining rises dramatically.
he level of this staining is affected neither by the oxygen level
n culture nor the presence of hydrogen peroxide, indicating that
he simple level of oxygen is inadequate to explain the increase.
urthermore, samples of placental villi collected by more conven-
ional curettage-based methods show strong staining for HIF1.
hese data indicate that the level of HIF1 is extremely sensitive
o the post-collection environment, but when the interval between
ollection and freezing is minimised, the levels are low. This is likely
o reﬂect the in vivo state. The HIF1 that is detected by immuno-
taining is functionally active as the level of vascular endothelial
rowth factor A (VEGFA) mRNA rises and placental growth factor
PlGF) mRNA decreases upon culture of the villi. This response is
ndependent of oxygen and the response (in terms of VEGFA mRNA
nduction) can be largely blocked by inhibiting the action of the p38
tress kinase (Cindrova-Davies et al., 2014).
Thus, while the placenta in pre-eclampsia may  well experience
 variety of forms of stress it is inaccurate to say that the normal
tate of the ﬁrst-trimester villi in human pregnancy is “hypoxic”.
. Endoplasmic reticulum stress
Endoplasmic reticulum stress may  be more accurately described
s the unfolded proteins response (UPR), or the uniﬁed stress
esponse. These different names reﬂect the fact that multiple differ-
nt stresses induce similar changes and that much of the response
s dependent on the presence of unfolded proteins present in the
ndoplasmic reticulum. Proteins that are to be secreted or glyco-
ylated are translated by the ribosomes on the rough endoplasmic
eticulum and translocated into the lumen of the ER. Here, they
re in an environment that facilitates correct three-dimensional
olding (owing to the appropriate ionic environment, pH and the
resence of chaperones and protein disulphide isomerases). They
re also partially glycosylated, a process that continues in the Golgi
pparatus. These processes are homeostatically regulated and theive Immunology 114 (2016) 81–85
cell is able to sense the presence of unfolded proteins and modu-
late its metabolism accordingly. For example, under conditions of
elevated ER stress there is an increase in transcription of a speciﬁc
subset of genes that lead to an increase in the ER protein folding
capacity (Yamamoto et al., 2007). PERK and IRE1 mediate trans-
lational control; in the case of PERK, by phosphorylating eIF2 to
suppress translation and IRE1 induces mRNA decay, also reducing
the translation load and hence the necessity for folding capacity
within the ER (Oakes and Papa, 2015; Walter and Ron, 2011).
Speciﬁc phosphorylation of serine 51 in eIF2 is a rapidly
induced switch to control translation–phosphorylation inhibiting
cap-dependent translation. Mutation of this serine (such that eIF2
cannot be phosphorylated and therefore cannot be inactivated by
PERK or other kinases) leads to profound ER stress (Scheuner et al.,
2001). We  have shown previously that mice bearing this muta-
tion show marked ER stress in the junctional zone of the placenta,
whereas the labyrinth (the transfer region) of the placenta is rel-
atively unaffected (Yung et al., 2012). The differentiation of the
various placental cells and the placenta is also altered. The in vitro
differentiation of trophoblast stem cells can also be modulated by
conditioned media obtained from mutant or wild type ﬁbroblasts.
This indicates that the factors produced by these ﬁbroblasts are
sensitive to ER stress and that their functions can be perturbed in
such a way  that the normal course of trophoblast differentiation is
altered (Yung et al., 2012).
However, while this is clear in the mouse, it is not possible to
use similar methods in the study of humans. Nonetheless, we have
evidence that ER stress is a feature of pre-eclampsia and the severity
of this may  also shed light on maternal sensitivity to this condition
(Yung et al., 2014).
We  evaluated the phosphorylation level of many of the effec-
tors and mediators of the UPR and several of the kinases activated
in the stress response pathway. We  have tested samples of placenta
collected from either normotensive term controls or from patients
with pre-eclampsia who were delivered by caesarean section. The
requirement for caesarean delivery was  used as the indicator of the
severity of maternal disease and the gestational age at the time of
caesarean noted. The samples are deﬁned by the gestational age at
caesarean, and not at the time of the onset of disease. Hierarchi-
cal clustering of these data reveals that all the placentas delivered
owing to clinical necessity at <34 weeks cluster in one branch and
all but 2 of those delivered ≥34 weeks and all the normotensive
controls cluster in the other major branch; indicating the similarity
among placentas in the latter two groups (Fig. 1) (Yung et al., 2014).
These ﬁndings support the concept that cases of early-onset pre-
eclampsia are predominantly due to placental abnormalities, while
those of late-onset pre-eclampsia are likely the result of increased
maternal sensitivity to the pro-inﬂammatory environment of preg-
nancy, because of metabolic or other disturbances (Yung et al.,
2014).
4. Dominant negative action of sFLT1, sensitising
endothelial cells
One consequence of the placental “stress” whether oxida-
tive, endoplasmic reticulum or immunological is that factors
are released into maternal circulation which affect the internal
endothelium leading to the maternal syndrome. There has been
considerable interest in the possible role of PlGF and soluble FLT1
and these factors (along with others) are being evaluated as possi-
ble biomarkers (predictive) of pre-eclampsia (Benton et al., 2011;
Rana et al., 2014). It has also been suggested that sFLT1 might
directly contribute to maternal endothelial dysfunction (Maynard
et al., 2003; Powe et al., 2011). However, the presence of these
factors and soluble endoglin has been more recently described
D.S. Charnock-Jones / Journal of Reproductive Immunology 114 (2016) 81–85 83
Fig. 1. Hierarchical clustering of placentas based on the analysis of ER stress response and signalling intermediates. Red squares represent placenta delivered for clinical
































tecessity before 34 weeks’ gestation, green triangles indicate placentas delivered a
s “the anti-angiogenic state”, although this phrase does presup-
ose that angiogenesis occurs during pregnancy and that these
actors in some way interfere with this. Clearly, angiogenesis does
ccur in the placenta, but once placentation is complete there is
ittle angiogenesis in the decidua. A distinction needs to be made
etween angiogenesis (the growth of new blood vessels from pre-
xisting vessels) and vascular remodelling, which clearly occurs
n the decidual spiral arteries. Nonetheless, even if there is little
aternal angiogenesis, it is highly likely that the presence of these
actors in the maternal circulation can have a direct effect on the
aternal endothelium.
Vascular endothelial growth factor A (VEGFA) is widely recog-
ised as a potent angiogenic factor that is produced by numerous
ifferent cell types and acts directly on endothelial cells to promote
ascular permeability, endothelial proliferation and migration
Ferrara et al., 2003). It is also a heparin-binding growth factor and
s therefore capable of being bound and sequestered by extracellu-
ar matrix and heparan sulphate proteoglycans from which it can
e released by the action of proteases (Houck et al., 1992; Keyt et al.,
996). These biochemical properties for VEGFA complicate a simple
nterpretation of its actions. Further complication is caused by the
act that endothelial cells themselves produce VEGFA; indeed, they
re dependent on it for survival (Lee et al., 2007). This is represented
n cartoon form in Fig. 2 in which the VEGF homodimer is released
y the endothelial cell and acts directly on one or other of the VEGF
eceptors. Heterodimers for the VEGF receptors are also present on
ndothelial cells and VEGFA may  act through such heterodimers
Barleon et al., 1997; Cudmore et al., 2012). It is also possible that
he actions take place entirely within the endothelial cell, a so-
alled “intracrine” effect (Liu et al., 2012). This has been shown
s a mechanism by which VEGFA mediates the survival of imma-
ure haematopoietic cells (Gerber et al., 2002). It is well recognised
hat soluble FLT1 is a very effective inhibitor of VEGF as it binds
Fig. 2. Schematic of (A) the autocrine action of VEGFA on endothelial cells, and (B),
the  dominant negative actions of sFLT1.













































differentiation. J. Clin. Invest. 122, 3101–3113, http://dx.doi.org/10.1172/ig. 3. Summary of the complex interaction of some the VEGF family members,
EGF receptors and cell surface heparan sulphate proteoglycans.
o VEGFA with high afﬁnity and effectively competes with the cell
urface membrane-bound receptors for free VEGFA (Kendall and
homas, 1993). However, the soluble receptor is also able to form
eterodimer with the cell surface receptors and thereby inhibit any
ignalling action that they may  have. This mechanism of action
f soluble FLT1 is frequently overlooked and interaction with the
ndothelial cells in this manner has the potential to subtly alter
ndothelial cell behaviour over a long time period.
We have previously shown that pre-incubation of endothelial
ells with soluble FLT1 profoundly alters the sensitivity of these
ndothelial cells to low doses of TNF (Cindrova-Davies et al.,
011). This is reﬂected in the binding of leucocytes to these cells, the
evel of ICAM, VCAM, Von Willebrand factor and endothelin. This
ensitisation of the endothelial cells is dependent on VEGF recep-
or signalling, as the enhancement of sensitivity can be blocked
y a tyrosine kinase inhibitor (SU5614) anti-KDR, anti-FLT1 anti-
odies and also siRNAs targeting KDR and FLT1. In each of these
nstances, the sensitivity to TNF is increased, but this is not further
nhanced by pre-treatment with soluble FLT1. These data impli-
ate the endogenous VEGF receptors in cellular sensitivity to TNF
Cindrova-Davies et al., 2011). These data provide a mechanism
y which the circulating level of sFLT1 may  inﬂuence multiple
ndothelial endpoints, many of which have been previously shown
o be dysregulated in pre-eclampsia.
The complex interactions between VEGF family members (par-
icularly VEGFA and PlGF) the membrane-bound forms of the
eceptor, and the soluble receptor are all further complicated by
he fact that each of these interacts with heparan sulphate proteo-
lycans on the cell surface and it is not clear how they affect the
ntracellular signals required for endothelial cell maintenance and
uiescence (illustrated in Fig. 3).
. Conclusion
The placenta is subject to a variety of stimuli to which it must
dapt, with the level of oxygen receiving the most attention. The
ormal pO2 in the intervillous space in the ﬁrst trimester of human
regnancy is low, but should not be described as hypoxic. sFLT1
s released from the placenta under a variety of “stress” con-
itions and is strongly implicated in the maternal syndrome of
re-eclampsia. It can directly affect endothelial cells by forming
eterodimers with cell surface receptors and can, at least in vitro,
lter the endothelial sensitivity to TNF. However, the interactions
mong VEGF family members, cell-surface VEGF receptors and hep-
ran sulphate proteoglycans are complex and the local effects hard
o predict. Nonetheless, it is likely that this will be a factor con-
ributing to variation in maternal sensitivity to pre-eclampsia.ive Immunology 114 (2016) 81–85
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